Page last updated: 2024-11-04

risedronic acid and Bone Stress Reaction

risedronic acid has been researched along with Bone Stress Reaction in 6 studies

Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.

Research Excerpts

ExcerptRelevanceReference
"One of the patients was treated with alendronate therapy in concern of her risk factors for osteoporosis (her previous a hysterectomy with bilateral oophorectomy) with unsubstantiated evidence of her pretreatment, bone-mineral-density measurements (BMD), for a 10-year prior episode of left prodromal thigh pain and an insufficiency fracture at 8 days post experiencing the pain."3.77Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases. ( Angthong, C; Angthong, W, 2011)
" We conclude that prophylactic treatment with risedronate in a training population at high risk for stress fracture using a maintenance dosage for the treatment of osteoporosis does not lower stress fracture risk."2.71The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits. ( Burr, D; Finestone, A; Goldich, Y; Kaufman, S; Kreiss, Y; Liebergall, M; Milgrom, C; Novack, V; Pereg, D; Zimlichman, E, 2004)
"After the pain is resolved and the examination shows improvement, patients may gradually increase their level of activity."2.47Stress fractures: diagnosis, treatment, and prevention. ( Kapil, N; Patel, DS; Roth, M, 2011)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aspenberg, P1
Schilcher, J1
Fahlgren, A1
Kidd, LJ1
Cowling, NR1
Wu, AC1
Kelly, WL1
Forwood, MR1
Patel, DS1
Roth, M1
Kapil, N1
Angthong, C1
Angthong, W1
Milgrom, C1
Finestone, A1
Novack, V1
Pereg, D1
Goldich, Y1
Kreiss, Y1
Zimlichman, E1
Kaufman, S1
Liebergall, M1
Burr, D1
Shiraki, M1

Reviews

2 reviews available for risedronic acid and Bone Stress Reaction

ArticleYear
Stress fractures: diagnosis, treatment, and prevention.
    American family physician, 2011, Jan-01, Volume: 83, Issue:1

    Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Calcium, Diet

2011
[Risedronate: clinical usage].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 3

    Topics: Bone Density; Clinical Trials as Topic; Etidronic Acid; Femoral Neck Fractures; Fractures, Stress; H

2002

Trials

1 trial available for risedronic acid and Bone Stress Reaction

ArticleYear
The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits.
    Bone, 2004, Volume: 35, Issue:2

    Topics: Etidronic Acid; Fractures, Stress; Humans; Incidence; Israel; Male; Military Personnel; Risedronic A

2004

Other Studies

3 other studies available for risedronic acid and Bone Stress Reaction

ArticleYear
Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack.
    Acta orthopaedica, 2010, Volume: 81, Issue:4

    Topics: Alendronate; Bone Density Conservation Agents; Bone Nails; Bone Resorption; Etidronic Acid; Female;

2010
Bisphosphonate treatment delays stress fracture remodeling in the rat ulna.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2011, Volume: 29, Issue:12

    Topics: Animals; Bone Density Conservation Agents; Bone Remodeling; Bony Callus; Diaphyses; Diphosphonates;

2011
Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2011, Volume: 94 Suppl 7

    Topics: Aged; Alendronate; Bone Density Conservation Agents; Drug Administration Schedule; Etidronic Acid; F

2011